Photodynamic therapy in the esophagus

Spechler, 2002, Barrett’s esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis, and therapy [review], Med. Clin. N. Am., 86, 1423, 10.1016/S0025-7125(02)00082-2 Sampliner, 2002, Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus, Am. J. Gastroenterol., 97, 1888, 10.1111/j.1572-0241.2002.05910.x Hirota, 1999, Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data, Gastroenterology, 116, 277, 10.1016/S0016-5085(99)70123-X van den Boogert, 1999, Endoscopic ablation therapy for Barrett’s esophagus with high-grade dysplasia [review], Am. J. Gastroenterol., 94, 1153, 10.1016/S0002-9270(99)00114-8 McCaughan, 1984, Palliation of esophageal malignancy with photoradiation therapy, Cancer, 54, 2905, 10.1002/1097-0142(19841215)54:12<2905::AID-CNCR2820541215>3.0.CO;2-N Barr, 2001, Review article: the potential role for photodynamic therapy in the management of upper gastrointestinal disease [review], Ali Pharm. Ther., 15, 311, 10.1046/j.1365-2036.2001.00936.x Kelty, 2002, Photodynamic therapy for Barrett’s esophagus [review], Dis. Esophagus, 15, 137, 10.1046/j.1442-2050.2002.00243.x Overholt, 2003, Photodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma: long-term results, Gastrointest Endosc., 58, 183, 10.1067/mge.2003.327 Panjehpour, 2000, Light sources and delivery devices for photodynamic therapy in the gastrointestinal tract [review], Gastrointest. Endosc. Clin. N. Am., 10, 513, 10.1016/S1052-5157(18)30120-X Overholt, 1993, A centering balloon for photodynamic therapy of esophageal cancer tested in a canine model, Gastrointest. Endosc., 39, 782, 10.1016/S0016-5107(93)70265-5 Gossner, 1999, A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia, Endoscopy, 31, 370, 10.1055/s-1999-31 van Veen, 2002, In situ light dosimetry during photodynamic therapy of Barrett’s esophagus with 5-aminolevulinic acid, Lasers Surg. Med., 31, 299, 10.1002/lsm.10129 Overholt, 1996, Balloon photodynamic therapy of esophageal cancer: effect of increasing balloon size, Lasers Surg. Med., 18, 248, 10.1002/(SICI)1096-9101(1996)18:3<248::AID-LSM5>3.0.CO;2-S Stepinac, 2002, Optimization of the diameter of a radial irradiation device for photodynamic therapy in the esophagus, Endoscopy, 34, 411, 10.1055/s-2002-25280 Panjehpour, 2000, Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett’s esophagus and effect of oral steroids on stricture formation, Am. J. Gastroenterol., 95, 2177, 10.1111/j.1572-0241.2000.02300.x Lightdale, 1995, Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial, Gastrointest. Endosc., 42, 507, 10.1016/S0016-5107(95)70002-1 Barr, 2000, Barrett’s esophagus: treatment with 5-aminolevulinic acid photodynamic therapy [review], Gastrointest. Endosc. Clin. N. Am., 10, 421, 10.1016/S1052-5157(18)30114-4 van den Boogert, 1999, Kinetics, localization, and mechanism of 5-aminolevulinic acid-induced porphyrin accumulation in normal and Barrett’s-like rat esophagus, Lasers Surg. Med., 24, 3, 10.1002/(SICI)1096-9101(1999)24:1<3::AID-LSM3>3.0.CO;2-N Ackroyd, 1999, 5-Aminolevulinic acid photosensitization of dysplastic Barrett’s esophagus: a pharmacokinetic study, Photochem. Photobiol., 70, 656 Hinnen, 2000, Porphyrin biosynthesis in human Barrett’s oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid, Br. J. Cancer, 83, 539, 10.1054/bjoc.2000.1300 Biddlestone, 1998, The histopathology of treated Barrett’s esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy, Am. J. Surg. Pathol., 22, 239, 10.1097/00000478-199802000-00013 Maier A, Tomaselli F, Matzi V, Rehak P, Pinter H, Smolle-Juttner. Photosensitization with hematoporphyrin derivative compared to 5-aminolaevulinic acid for photodynamic therapy of esophageal carcinoma. Ann Thoracic Surg 2001;72:1136–40. Hinnen, 2002, Timing of 5-aminolaevulinic acid-induced photodynamic therapy for the treatment of patients with Barrett’s oesophagus, J. Photochem. Photobiol. B: Biol., 68, 8, 10.1016/S1011-1344(02)00324-X van Den Boogert, 2000, Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity, J. Photochem. Photobiol. B: Biol., 56, 53, 10.1016/S1011-1344(00)00059-2 van Den Boogert, 2001, Fractionated illumination for oesophageal ALA-PDT: effect on blood flow and PPIX formation, Lasers Med. Sci., 16, 16, 10.1007/PL00011331 Pech, 2002, Photodynamic therapy of human Barrett’s cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice, Eur. J. Gastroenterol. Hepatol., 14, 657, 10.1097/00042737-200206000-00011 Hinnen, 2002, Two course illuminating scheme improves aminolevulinic acid photodynamic therapy in cell cultures, Cell. Mol. Biol., 48, 903 Brunner, 2003, New 5-aminolevulinic acid esters—efficient protoporphyrin precursors for photodetection and photodynamic therapy, Photochem. Photobiol., 78, 481, 10.1562/0031-8655(2003)078<0481:NAAEPP>2.0.CO;2 Radu, 2003, Mucosal ablation with photodynamic therapy in the esophagus: optimization of light dosimetry in the sheep model, Gastrointest. Endosc., 57, 897, 10.1016/S0016-5107(03)70027-3 Javaid, 2002, Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with m-THPC (m-tetrahydroxyphenyl chlorin): a preliminary study, Lasers Med. Sci., 17, 51, 10.1007/s10103-002-8266-5 May, 2002, Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett’s oesophagus: acute-phase and intermediate results of a new treatment approach, Eur. J. Gastroenterol. Hepatol., 14, 1085, 10.1097/00042737-200210000-00009 Aveline, 1994, Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA), Photochem. Photobiol., 59, 328, 10.1111/j.1751-1097.1994.tb05042.x Waterfield, 1994, Wavelength-dependent effects of benzoporphyrin derivative monoacid ring A in vivo and in vitro, Photochem. Photobiol., 60, 383, 10.1111/j.1751-1097.1994.tb05120.x Pandey, 1995, Evaluation of new benzoporphyrin derivatives with enhanced PDT efficacy, Photochem. Photobiol., 62, 764, 10.1111/j.1751-1097.1995.tb08727.x Fingar, 1999, Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD), Br. J. Cancer, 79, 1702, 10.1038/sj.bjc.6690271 Andrejevic Blant, 2000, Time-dependent biodistribution of tetra (m-hydroxyphenyl) chlorin and benzoporphyrin derivative monoacid ring A in the hamster model: comparative fluorescence microscopy study, Photochem. Photobiol., 71, 333, 10.1562/0031-8655(2000)0710333TDBOTM2.0.CO2 Panjehpour, 2002, Photodynamic therapy using Verteporfin (benzoporphyrin derivative monoacid ring A, BPD-MA) and 630nm laser light in canine esophagus, Lasers Surg. Med., 30, 26, 10.1002/lsm.10014 Bellnier, 2003, Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients, Cancer Res., 63, 1806 Bays, 1997, Light dosimetry for photodynamic therapy in the esophagus, Lasers Surg. Med., 20, 290, 10.1002/(SICI)1096-9101(1997)20:3<290::AID-LSM8>3.0.CO;2-L Maier, 2000, Combined photodynamic therapy and hyperbaric oxygenation in carcinoma of the esophagus and the esophago-gastric junction, Eur. J. Cardio-Thorac. Surg., 18, 649, 10.1016/S1010-7940(00)00592-3 Panjehpour, 1992, Comparative study between pulsed and continuous wave lasers for Photofrin photodynamic therapy, Lasers Surg. Med., 13, 296, 10.1002/lsm.1900130306 Barr, 2001, The potential role for photodynamic therapy in the management of upper gastrointestinal disease [review], Ali Pharm. Ther., 15, 311, 10.1046/j.1365-2036.2001.00936.x Kelty, 2002, Photodynamic therapy for Barrett’s esophagus [review], Dis. Esophagus, 15, 137, 10.1046/j.1442-2050.2002.00243.x Panjehpour, 2000, Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett’s esophagus and effect of oral steroids on stricture formation, Am. J. Gastroenterol., 95, 2177, 10.1111/j.1572-0241.2000.02300.x Overholt, 1997, Photodynamic therapy for Barrett’s esophagus: cardiac effects, Lasers Surg. Med., 21, 317, 10.1002/(SICI)1096-9101(1997)21:4<317::AID-LSM2>3.0.CO;2-T Malhi-Chowla, 2001, Esophageal dysmotility in patients undergoing photodynamic therapy, Mayo Clin. Proc., 76, 987, 10.4065/76.10.987 Heier, 1995, Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd:YAG laser therapy, Gastroenterology, 109, 63, 10.1016/0016-5085(95)90269-4 Lightdale, 2000, Role of photodynamic therapy in the management of advanced esophageal cancer [review], Gastrointest. Endosc. Clin. N. Am., 10, 397, 10.1016/S1052-5157(18)30112-0 Raijman, 1995, Photodynamic therapy for tumor ingrowth through an expandable esophageal stent, Gastrointest. Endosc., 41, 73, 10.1016/S0016-5107(95)70281-4 Scheider, 1997, Photodynamic therapy for the treatment of tumor ingrowth in expandable esophageal stents, Endoscopy, 29, 271, 10.1055/s-2007-1004188 Sibille, 1995, Long-term survival after photodynamic therapy for esophageal cancer, Gastroenterology, 108, 337, 10.1016/0016-5085(95)90058-6 Maier, 2000, Effect of photodynamic therapy in a multimodal approach for advanced carcinoma of the gastro-esophageal junction, Lasers Surg. Med., 26, 461, 10.1002/1096-9101(2000)26:5<461::AID-LSM5>3.0.CO;2-T Ferguson, 1997, Resection for Barrett’s mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy, J. Thorac. Cardiovasc. Surg., 114, 824, 10.1016/S0022-5223(97)70087-4 Hur, 2003, Cost-effectiveness of photodynamic therapy for treatment of Barrett’s esophagus with high-grade dysplasia, Dig. Dis. Sci., 48, 1273, 10.1023/A:1024146823549 Buttar, 2001, Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett’s esophagus, Gastrointest. Endosc., 54, 682 Overholt, 2000, Acid suppression and reepithelialization after ablation of Barrett’s esophagus [review], Dig. Dis., 18, 232, 10.1159/000051404 Krishnadath, 2000, Persistent genetic abnormalities in Barrett’s esophagus after photodynamic therapy, Gastroenterology, 119, 624, 10.1053/gast.2000.18012 Fitzgerald, 2001, Significance of genetic abnormalities after photodynamic therapy [letter], Gastroenterology, 120, 1064, 10.1053/gast.2001.23099 Savary, 1998, Photodynamic therapy of early squamous cell carcinomas of the esophagus: a review of 31 cases, Endoscopy, 30, 258, 10.1055/s-2007-1001252 Gossner, 1998, Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid, Gastroenterology, 114, 448, 10.1016/S0016-5085(98)70527-X May, 2002, Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett’s oesophagus: acute-phase and intermediate results of a new treatment approach, Eur. J. Gastroenterol. Hepatol., 14, 1085, 10.1097/00042737-200210000-00009 Ackroyd, 2000, Photodynamic therapy for dysplastic Barrett’s oesophagus: a prospective, double blind, randomised, placebo-controlled trial, Gut, 47, 612, 10.1136/gut.47.5.612